CA2996383C - Compositions d'immunomodulation et leurs procedes d'utilisation - Google Patents

Compositions d'immunomodulation et leurs procedes d'utilisation

Info

Publication number
CA2996383C
CA2996383C CA2996383A CA2996383A CA2996383C CA 2996383 C CA2996383 C CA 2996383C CA 2996383 A CA2996383 A CA 2996383A CA 2996383 A CA2996383 A CA 2996383A CA 2996383 C CA2996383 C CA 2996383C
Authority
CA
Canada
Prior art keywords
fold
individual
immunomodulatory composition
cells
present disclosure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2996383A
Other languages
English (en)
Other versions
CA2996383A1 (fr
Inventor
Babita Agrawal
Rakesh Kumar
Nancy GUPTA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority claimed from PCT/IB2016/055016 external-priority patent/WO2017033123A1/fr
Publication of CA2996383A1 publication Critical patent/CA2996383A1/fr
Application granted granted Critical
Publication of CA2996383C publication Critical patent/CA2996383C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

La présente invention concerne des compositions d'immunomodulation qui comprennent le Caulobacter crescentus (CC) vivant. Des compositions d'immunomodulation de la présente invention sont utiles pour moduler une réponse immunitaire chez un individu. La présente invention concerne ainsi des procédés, pour moduler une réponse immunitaire chez un individu, qui consistent à administrer une composition d'immunomodulation comprenant le CC vivant à l'individu.
CA2996383A 2015-08-25 2016-08-22 Compositions d'immunomodulation et leurs procedes d'utilisation Active CA2996383C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562209693P 2015-08-25 2015-08-25
US62/209,693 2015-08-25
PCT/IB2016/055016 WO2017033123A1 (fr) 2015-08-25 2016-08-22 Compositions d'immunomodulation et leurs procédés d'utilisation

Publications (2)

Publication Number Publication Date
CA2996383A1 CA2996383A1 (fr) 2017-03-02
CA2996383C true CA2996383C (fr) 2025-12-09

Family

ID=

Similar Documents

Publication Publication Date Title
US11701393B2 (en) Immunomodulatory compositions and methods of use thereof
US10946082B2 (en) Immunomodulatory compositions and methods of use thereof
RU2617058C2 (ru) Фармацевтическая композиция, содержащая комплекс полимерного носителя и переносимого вещества и по меньшей мере один белковый или пептидный антиген
JP2025061056A (ja) 異なる核酸アジュバントの組み合わせによる、新規Ｔｈ１誘導性アジュバントおよびその用途
CA3170493A1 (fr) Vaccin a base d'acide nucleique exosomal concu de facon modulaire pour exploiter de multiples mecanismes de presentation d'antigenes
US20110293658A1 (en) Use of inkt or tlr agonists for protecting against or treating a disease such as acute infection or cancer
US20100285055A1 (en) Activation of natural killer (NK) cells and methods of use
US20240115693A1 (en) Sars-cov-2 antigen nanoparticles and uses there of
CN103990120B (zh) 抗感染剂及其用途
CA2996383C (fr) Compositions d'immunomodulation et leurs procedes d'utilisation
US20220257753A1 (en) Vaccine Adjuvants for Antigen Delivery
HK1227730B (en) Immunomodulatory compositions and methods of use thereof
HK1227730A1 (en) Immunomodulatory compositions and methods of use thereof